These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 26632310)

  • 1. Efavirenz as a cause of ataxia in children.
    Hauptfleisch MP; Moore DP; Rodda JL
    S Afr Med J; 2015 Nov; 105(11):897-8. PubMed ID: 26632310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brief Report: Late Efavirenz-Induced Ataxia and Encephalopathy: A Case Series.
    Variava E; Sigauke FR; Norman J; Rakgokong M; Muchichwa P; Mochan A; Maartens G; Martinson NA
    J Acquir Immune Defic Syndr; 2017 Aug; 75(5):577-579. PubMed ID: 28520619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of side effects with 2 doses of the HIV drug efavirenz.
    Ann Intern Med; 2009 Aug; 151(3):I24. PubMed ID: 19581632
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma concentrations of efavirenz are associated with body weight in HIV-positive individuals.
    Poeta J; Linden R; Antunes MV; Real L; Menezes AM; Ribeiro JP; Sprinz E
    J Antimicrob Chemother; 2011 Nov; 66(11):2601-4. PubMed ID: 21890538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The challenge of paediatric efavirenz dosing: implications and way forward for the sub-Saharan Africa.
    Mukonzo JK
    AIDS; 2014 Aug; 28(13):1855-7. PubMed ID: 25259700
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiviral efficacy, tolerability and pharmacokinetics of efavirenz in an unselected cohort of HIV-infected children.
    Wintergerst U; Hoffmann F; Jansson A; Notheis G; Huss K; Kurowski M; Burger D
    J Antimicrob Chemother; 2008 Jun; 61(6):1336-9. PubMed ID: 18343800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse Neuropsychiatric Events and Recreational Use of Efavirenz and Other HIV-1 Antiretroviral Drugs.
    Dalwadi DA; Ozuna L; Harvey BH; Viljoen M; Schetz JA
    Pharmacol Rev; 2018 Jul; 70(3):684-711. PubMed ID: 29945900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infection or drug toxicity? Acute ataxia and encephalopathy after uncomplicated falciparum malaria and efavirenz dose adjustment.
    Brasher WP; Bvumbwe M; Kazembe PN
    Malawi Med J; 2020 Dec; 32(4):229-231. PubMed ID: 34457209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of a relation between efavirenz plasma concentrations and toxicity-driven efavirenz discontinuations in the EuroSIDA study.
    van Luin M; Bannister WP; Mocroft A; Reiss P; Di Perri G; Peytavin G; Molto J; Karlson A; Castagna A; Beniowski M; Lundgren JD; Burger DM;
    Antivir Ther; 2009; 14(1):75-83. PubMed ID: 19320239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switching from efavirenz to nevirapine in children: 1-week dose escalation strategy.
    Udomphanit T; Lumbiganon P; Rattanamanee S; Harnlakorn P; Sopharak C; Sringam J; Anutchatchaval S; Tharnprisan P; Kosalaraksa P
    AIDS Res Hum Retroviruses; 2014 Aug; 30(8):727-9. PubMed ID: 24921980
    [No Abstract]   [Full Text] [Related]  

  • 11. Potential benefits of cyproheptadine in HIV-positive patients under treatment with antiretroviral drugs including efavirenz.
    Dabaghzadeh F; Khalili H; Ghaeli P; Dashti-Khavidaki S
    Expert Opin Pharmacother; 2012 Dec; 13(18):2613-24. PubMed ID: 23140169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver toxicity associated with antiretroviral therapy including efavirenz or ritonavir-boosted protease inhibitors in a cohort of HIV/hepatitis C virus co-infected patients.
    Neukam K; Mira JA; Ruiz-Morales J; Rivero A; Collado A; Torres-Cornejo A; Merino D; de Los Santos-Gil I; Macías J; González-Serrano M; Camacho A; Parra-García G; Pineda JA;
    J Antimicrob Chemother; 2011 Nov; 66(11):2605-14. PubMed ID: 21903660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No observable correlation between central nervous system side effects and EFV plasma concentrations in Japanese HIV type 1-infected patients treated with EFV containing HAART.
    Takahashi M; Ibe S; Kudaka Y; Okumura N; Hirano A; Suzuki T; Mamiya N; Hamaguchi M; Kaneda T
    AIDS Res Hum Retroviruses; 2007 Aug; 23(8):983-7. PubMed ID: 17725414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efavirenz plasma concentrations did not predict cessation of therapy due to neuropsychiatric symptoms in a large randomized trial.
    Read TR; Carey D; Mallon P; Mijch A; Goodall R; Hudson F; Wand H; Emery S
    AIDS; 2009 Oct; 23(16):2222-3. PubMed ID: 19773634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efavirenz-induced exfoliative dermatitis.
    Zhang JC; Sun YT
    Scand J Infect Dis; 2013 Jan; 45(1):70-2. PubMed ID: 22715849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A paediatric case of acute liver failure associated with efavirenz-based highly active antiretroviral therapy and effective use of raltegravir in combination antiretroviral treatment after liver transplantation.
    Turkova A; Ball C; Gilmour-White S; Rela M; Mieli-Vergani G
    J Antimicrob Chemother; 2009 Mar; 63(3):623-5. PubMed ID: 19164417
    [No Abstract]   [Full Text] [Related]  

  • 17. Switching from efavirenz to nevirapine.
    Gelinck LB; Burger DM
    Clin Infect Dis; 2010 Aug; 51(3):365; author reply 365-6. PubMed ID: 20578877
    [No Abstract]   [Full Text] [Related]  

  • 18. Efavirenz induced acute liver failure requiring liver transplantation in a slow drug metaboliser.
    Elsharkawy AM; Schwab U; McCarron B; Burt AD; Daly AK; Hudson M; Masson S
    J Clin Virol; 2013 Sep; 58(1):331-3. PubMed ID: 23763943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychiatric symptoms associated with efavirenz: prevalence, correlates, and management. A neurobehavioral review.
    Muñoz-Moreno JA; Fumaz CR; Ferrer MJ; González-García M; Moltó J; Negredo E; Clotet B
    AIDS Rev; 2009; 11(2):103-9. PubMed ID: 19529750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efavirenz: innocent bystander or direct nephrotoxin?
    Wyatt CM; Rodriguez-Caprio G; Klotman PE
    AIDS; 2007 Jun; 21(10):1393. PubMed ID: 17545729
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.